Metabolism of caffeine and theophylline in rats with malaria and endotoxin-induced fever

References

• Abdi F., Pollard I., Wilkinson J. Placental transfer and foetal disposition of caffeine and its immediate metabolites in the 20-day pregnant rat: function of dose. Xenobiotica 1993; 23: 449–456
   PubMed Web of Science ®Google Scholar
• Bachmann K. A., Yang C., Jahn D., Schwartz J. The use of single sample clearance estimates to probe hepatic drug metabolism in rats. I. Xenobiotica 1988; 18: 151–159
   PubMed Web of Science ®Google Scholar
• Butler M. A., Iwasaki M., Guengerich F. P., Kadluber F. F. Human cytochrome P-450PA(P-4501A2), the phenacetin O-deethylase, is primarily responsible for hepatic demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proceedings of the National Academy of Sciences, USA 1989; 86: 7696–7700
   PubMed Web of Science ®Google Scholar
• Chang K. C., Lauer B. A., Bell T. D., Chai H. Altered theophylline pharmacokinetics during respiratory viral illness. Lancet 1978; i: 1132–1133
   Google Scholar
• Clark C. J., Boyd G. Theophylline pharmacokinetics during respiratory viral infections. Lancet 1979; i: 492
   Google Scholar
• Colli A., Buccino G., Coccioli M., Parravicini R., Scaltrini G. Disposition of a flow-limited drug (lidocaine) and a metabolic capacity-limited drug (theophylline) in liver cirrhosis. Clinical Pharmacology and Therapeutics 1988; 44: 642–649
   Google Scholar
• Emudianughe T. S., Bickel Q. D., Taylor M. G., Andrews B. Effect of Plasmodium berghei infection on benzoic acid metabolism in mice. Experientia 1985; 41: 1407–1409
   Google Scholar
• Gorodischer R., Yaari A., Margalith M., Warszawski D., Ben-Zvi Z. Changes in theophylline metabolism during postnatal development in rat liver slices. Biochemical Pharmacology 1986; 35: 3077–3081
   PubMed Web of Science ®Google Scholar
• Hartley R., Smith I. J., Cookman J. R. Improved high-performance liquid chromatographic method for the simultaneous determination of caffeine and its N-demethylated metabolites in plasma using solid phase extraction. Journal of Chromatography 1985; 342: 105–117
   PubMed Web of Science ®Google Scholar
• Hendeles L., Weinberger M. Theophylline: a ‘state of the art’ review. Pharmacology 1993; 3: 2–44
   Google Scholar
• Ikeya K., Jaiswal A. K., Owens R. A., Jones J. E., Nebert D. W., Kimura S. Human CYP1A2: sequence, gene structure, comparison with the mouse and rat orthologous gene, and differences in the liver 1A2 mRNA expression. Molecular Endocrinology 1989; 3: 1399–1408
   PubMed Web of Science ®Google Scholar
• Jonkman J. H. G., Nicholson K. G., Farrow P. R., Eckert M., Grasmeijer G., Oosterhuis B., De Noord O. E., Guentert T. W. Effects of α-interferon on theophylline pharmacokinetics and metabolism. British Journal of Clinical Pharmacology 1989; 27: 795–802
   PubMed Web of Science ®Google Scholar
• Joeres R., Klinker H., Heusler H., Epping J., Zilly W., Richter E. Influence of smoking on caffeine elimination in healthy volunteers and in patients with alcoholic liver cirrhosis. Hepatology 1988; 8: 575–579
   PubMed Web of Science ®Google Scholar
• Kokwaro G. O., Glazier A. P., Ward S. A., Breckenridge A. M., Edwards G. Effect of malaria infection and endotoxic-induced fever on phenacetin O-deethylation by rat liver microsomes. Biochemical Pharmacology 1993; 45: 1235–1241
   PubMed Web of Science ®Google Scholar
• Kraan J., Jonkman J. H. G., Koeter G. H., Gips C. H., De Jong P. E., Van Der Mark Th. W., De Ekman I., Zeeuw R. A. The pharmacokinetics of theophylline and enprofylline in patients with liver cirrhosis and patients with chronic renal disease. European Journal of Clinical Pharmacology 1988; 35: 357–362
   Google Scholar
• Kraemer M. J., Furakawa C. T., Koup J. R., Shapiro G., Pierson W. E., Bierman C. W. Altered theophylline clearance during an influenza B outbreak. Pediatrics 1982; 69: 476–479
   PubMed Web of Science ®Google Scholar
• Leakey T. E. B. Simultaneous analysis of theophylline, caffeine and eight of their metabolic products in human plasma by gradient high-performance liquid chromatography. Journal of Chromatography 1990; 507: 199–220
   PubMed Web of Science ®Google Scholar
• Levy G. Renal clearance of theophylline in man. Journal of Clinical Pharmacology 1976; 16: 329–332
   PubMed Web of Science ®Google Scholar
• Mc Carthy J. S., Furner R. L., Van Dyke K., Stitzel R. E. Effect of malarial infection on host microsomal drug-metabolising enzymes. Biochemical Pharmacology 1970; 19: 1341–1349
   Google Scholar
• Mansor S. M., Ward S. A., Edwards G., Hoaksay P. E., Breckenridge A. M. The effect of malaria infection on the disposition of quinine and quinidine in the rat isolated perfused liver preparation. Journal of Pharmacy and Pharmacology 1990; 42: 428–438
   PubMed Web of Science ®Google Scholar
• Mansor S. M., Ward S. A., Edwards G. The effect of fever on quinine and quinidine disposition in the rat. Journal of Pharmacy and Pharmacology 1991; 43: 705–708
   PubMed Web of Science ®Google Scholar
• Mihaly G. W., Date N. M., Veenendaal J. R., Newman K. T., Smallwood R. A. Decreased hepatic elimination of pyrimethamine during malaria infection. Studies in the isolated perfused rat liver. Biochemical Pharmacology 1987; 36: 2827–2829
   PubMed Web of Science ®Google Scholar
• Murdoch R. T., Ghabrail H., Smallwood R. A., Morgan D. J. Effect of malaria on phenol conjugation pathways in perfused rat liver. Biochemical Pharmacology 1992; 43: 1229–1234
   Google Scholar
• Pilsgaard H., Poulsen H. E. A one-sample method for antipyrine clearance determination in rats. Pharmacology 1984; 29: 110–116
   PubMed Web of Science ®Google Scholar
• Renton K. W., Knickle L. C. Regulation of hepatic cytochrome P-450 during infectious diseases. Canadian Journal of Physiology and Pharmacology 1990; 68: 777–781
   PubMed Web of Science ®Google Scholar
• Rowland M., Tozer T. N. Clinical Pharmacokinetics. Concepts and Applications2nd Edn. Lea & Febiger, Philadelphia 1989; 148–176
   Google Scholar
• Sarker M. A., Hunt C., Guzelian P. S., Karnes H. T. Characterization of human liver cytochrome P-450 involved in theophylline metabolism. Drug Metabolism and Disposition 1992; 20: 31–37
   Google Scholar
• Sesardic D., Boobis A. R., Edwards R. J., Davies D. S. A form of cytochrome P-450 in man orthologous to form d in the rat catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking. British Journal of Clinical Pharmacology 1988; 26: 363–372
   PubMed Web of Science ®Google Scholar
• Tanaka E., Ishikawa A., Yamamoto Y., Uchida E., Kobayashi S., Yasuhara H., Misawa S. Simplified approach for evaluation of hepatic drug-oxidising capacity with a simultaneous measurement of caffeine and its primary demethylated metabolites in carbon tetrachloride-intoxicated rats. Xenobiotica 1992; 22: 535–541
   PubMed Web of Science ®Google Scholar
• Thiessen J. J., Poon K. Antipyrine pharmacokinetics in the rabbit during acute pyrogen-induced fever. Canadian Journal of Pharmaceutical Sciences 1979; 14: 92–95
   Google Scholar
• Upton R. A. Pharmacokinetic interaction between theophylline and other medications. Clinical Pharmacokinetics 1991; 20: 66–80
   PubMed Web of Science ®Google Scholar
• Wang L., Hasegawa T., Nadai M., Muraoka I., Nabeshima T., Kato N. The effect of lipopolysaccharide on the disposition of xanthines in rats. Journal of Pharmacy and Pharmacology 1993; 45: 34–38
   Google Scholar
• Wrighton S. A., Campanile C., Thomas P. E., Maines S. L., Watkins P. B., Parker G., Mendez-Picon G., Haniu M., Shively J. E., Levin W., Guzelian P. S. Identification of human cytochrome P-450 homologous to the major isosafrole-inducible cytochrome P-450 in the rat. Molecular Pharmacology 1986; 29: 405–410
   PubMed Web of Science ®Google Scholar
• Zeruesenay D., Siegmund W., Zschiesche M., Franke G., Walter R., Bleyer H. Pharmacokinetic interactions between isoniazid and theophylline in rats. Journal of Pharmacy and Pharmacology 1992; 44: 893–897
   Google Scholar